SAGE

Sage Therapeutics

Delisted

SAGE was delisted on the 30th of July, 2025.

73 hedge funds and large institutions have $735M invested in Sage Therapeutics in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$11.7M
2 +$6.96M
3 +$5.72M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$4.37M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$3.96M

Top Sellers

1 -$6.88M
2 -$5.06M
3 -$4.57M
4
Millennium Management
Millennium Management
New York
-$2.52M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.91M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.97M
27
$1.8M
28
$1.79M
29
$1.74M
30
$1.47M
31
$1.45M
32
$1.29M
33
$1.27M
34
$1.25M
35
$1.18M
36
$883K
37
$844K
38
$683K
39
$679K
40
$670K
41
$647K
42
$625K
43
$530K
44
$527K
45
$463K
46
$390K
47
$383K
48
$293K
49
$281K
50
$261K